L. H. Visser

1.5k total citations
14 papers, 991 citations indexed

About

L. H. Visser is a scholar working on Immunology, Neurology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, L. H. Visser has authored 14 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Neurology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in L. H. Visser's work include Peripheral Neuropathies and Disorders (5 papers), Immune Response and Inflammation (5 papers) and T-cell and B-cell Immunology (4 papers). L. H. Visser is often cited by papers focused on Peripheral Neuropathies and Disorders (5 papers), Immune Response and Inflammation (5 papers) and T-cell and B-cell Immunology (4 papers). L. H. Visser collaborates with scholars based in Netherlands, Germany and Indonesia. L. H. Visser's co-authors include Jan Meulstee, R. Beekman, P.I.M. Schmitz, Pieter A. van Doorn, Bart C. Jacobs, F.G.A. van der Meché, Rinske van Koningsveld, Jon D. Laman, P H Rothbarth and Marjan van Meurs and has published in prestigious journals such as The Lancet, The Journal of Immunology and Brain.

In The Last Decade

L. H. Visser

14 papers receiving 963 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
L. H. Visser 554 433 192 178 141 14 991
R. A. C. Hughes 1.4k 2.5× 805 1.9× 128 0.7× 252 1.4× 71 0.5× 47 1.7k
Marinos C. Dalakas 494 0.9× 405 0.9× 123 0.6× 76 0.4× 86 0.6× 24 1.4k
Edward Cupler 439 0.8× 252 0.6× 141 0.7× 54 0.3× 141 1.0× 53 1.3k
M. C. Dalakas 240 0.4× 163 0.4× 127 0.7× 66 0.4× 35 0.2× 21 711
Antoine Guéguen 244 0.4× 67 0.2× 181 0.9× 67 0.4× 45 0.3× 47 1.0k
J. M. Vallat 247 0.4× 208 0.5× 36 0.2× 70 0.4× 31 0.2× 28 530
J Gawler 207 0.4× 141 0.3× 25 0.1× 105 0.6× 67 0.5× 29 704
John A. Goodfellow 547 1.0× 314 0.7× 57 0.3× 43 0.2× 19 0.1× 16 715
Peter J. Spaeth 151 0.3× 41 0.1× 297 1.5× 61 0.3× 112 0.8× 25 806
Takafumi Sugimoto 289 0.5× 110 0.3× 41 0.2× 40 0.2× 354 2.5× 47 1.1k

Countries citing papers authored by L. H. Visser

Since Specialization
Citations

This map shows the geographic impact of L. H. Visser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. H. Visser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. H. Visser more than expected).

Fields of papers citing papers by L. H. Visser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. H. Visser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. H. Visser. The network helps show where L. H. Visser may publish in the future.

Co-authorship network of co-authors of L. H. Visser

This figure shows the co-authorship network connecting the top 25 collaborators of L. H. Visser. A scholar is included among the top collaborators of L. H. Visser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. H. Visser. L. H. Visser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Hiele, Karin van der, L. H. Visser, Menno M. Schoonheim, et al.. (2019). Introducing Multiple Screener: An unsupervised digital screening tool for cognitive deficits in MS. Multiple Sclerosis and Related Disorders. 38. 101479–101479. 16 indexed citations
2.
Hamann, Jörg, Henrike Veninga, L. H. Visser, et al.. (2010). CD97 in Leukocyte Trafficking. Advances in experimental medicine and biology. 706. 128–137. 13 indexed citations
3.
Visser, L. H., Marie‐José Melief, Debby van Riel, et al.. (2006). Phagocytes Containing a Disease-Promoting Toll-Like Receptor/Nod Ligand Are Present in the Brain during Demyelinating Disease in Primates. American Journal Of Pathology. 169(5). 1671–1685. 53 indexed citations
4.
Visser, L. H., Hendrik Jan de Heer, Leonie A. Boven, et al.. (2005). Proinflammatory Bacterial Peptidoglycan as a Cofactor for the Development of Central Nervous System Autoimmune Disease. The Journal of Immunology. 174(2). 808–816. 99 indexed citations
5.
Beekman, R. & L. H. Visser. (2004). High‐resolution sonography of the peripheral nervous system – a review of the literature. European Journal of Neurology. 11(5). 305–314. 138 indexed citations
6.
Koningsveld, Rinske van, et al.. (2004). Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial. The Lancet. 363(9404). 192–196. 235 indexed citations
7.
Maassen, C.B.M., Jon D. Laman, Conny van Holten-Neelen, et al.. (2003). Reduced experimental autoimmune encephalomyelitis after intranasal and oral administration of recombinant lactobacilli expressing myelin antigens. Vaccine. 21(32). 4685–4693. 25 indexed citations
8.
Visser, L. H., Alex F. de Vos, Jörg Hamann, et al.. (2002). Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis. Journal of Neuroimmunology. 132(1-2). 156–163. 46 indexed citations
9.
Laman, Jon D., L. H. Visser, C.B.M. Maassen, et al.. (2001). Novel monoclonal antibodies against proteolipid protein peptide 139–151 demonstrate demyelination and myelin uptake by macrophages in MS and marmoset EAE lesions. Journal of Neuroimmunology. 119(1). 124–130. 13 indexed citations
10.
Visser, L. H., et al.. (1999). IFN-β modulates specific T cell responses in vitro but does not affect Experimental Autoimmune Encephalomyelitis in the SJL mouse. Journal of Neuroimmunology. 100(1-2). 190–196. 15 indexed citations
11.
Meché, F.G.A. van der, L. H. Visser, Bart C. Jacobs, et al.. (1997). Guillain‐Barré Syndrome: Multifactorial Mechanisms versus Defined Subgroups. The Journal of Infectious Diseases. 176(s2). S99–S102. 42 indexed citations
12.
Visser, L. H., et al.. (1997). Cytomegalovirus infection and Guillain-Barre syndrome. Neurology. 49(5). 1473–1473. 3 indexed citations
13.
Visser, L. H., F.G.A. van der Meché, Jan Meulstee, et al.. (1996). Cytomegalovirus infection and Guillain-Barre syndrome. Neurology. 47(3). 668–673. 154 indexed citations
14.
Visser, L. H., F.G.A. van der Meché, Pieter A. van Doorn, et al.. (1995). Guillain-Barré syndrome without sensory loss (acute motor neuropathy). Brain. 118(4). 841–847. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026